<DOC>
	<DOCNO>NCT00764673</DOCNO>
	<brief_summary>The purpose study evaluate survivorship efficacy Encore 3DKnee™ system group patient receive 3DKnee™ primary ( first ) orthopedic implant knee . Each knee designate separate subject follow period 2 year .</brief_summary>
	<brief_title>The 3DKnee™ System : A Post-Market Study</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Necrosis</mesh_term>
	<criteria>This must primary knee replacement knee . Have knee joint disease relate one follow degenerative joint disease , include osteoarthritis traumatic arthritis Avascular necrosis femoral condyle Posttraumatic loss joint configuration , particularly patellofemoral erosion , dysfunction prior patellectomy Moderate valgus , varus , flexion deformity Rheumatoid arthritis Patient likely available evaluation duration study Able willing sign inform consent follow study procedure Patient pregnant Patient must 18 year age If total knee replacement knee past ( revision allow study ) Infection , history infection , acute chronic , local systemic Alcoholism addiction Muscular , neurological vascular deficiency compromise affected extremity Obesity Insufficient bone quality Loss ligamentous structure High level physical activity Materials sensitivity Prisoner Mental condition may interfere patient 's ability give inform consent willingness fulfill study requirement Patient pregnant Is young 18 year age</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2011</verification_date>
</DOC>